878197-67-2 Usage
General Description
5-FLUOROIMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE is a chemical compound with the molecular formula C8H6FN3O. It is a yellow solid that is used in the synthesis of pharmaceuticals and agrochemicals. 5-FLUOROIMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE is a heterocyclic aromatic aldehyde that contains a fluorine atom, an imidazole ring, and a pyridine ring in its structure. It is a versatile building block in organic synthesis and has potential applications in the development of new drugs and chemical products. Its unique structure and reactivity make it a valuable intermediate in the production of various compounds used in the pharmaceutical and agricultural industries.
Check Digit Verification of cas no
The CAS Registry Mumber 878197-67-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,8,1,9 and 7 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 878197-67:
(8*8)+(7*7)+(6*8)+(5*1)+(4*9)+(3*7)+(2*6)+(1*7)=242
242 % 10 = 2
So 878197-67-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H5FN2O/c9-7-2-1-3-8-10-6(5-12)4-11(7)8/h1-5H
878197-67-2Relevant articles and documents
Kilogram-scale synthesis of the CXCR4 antagonist GSK812397
Boggs, Sharon,Elitzin, Vassil I.,Gudmundsson, Kristjan,Martin, Michael T.,Sharp, Matthew J.
scheme or table, p. 781 - 785 (2010/04/22)
An improved, scalable synthesis of the CXCR4 antagonist GSK812397 is described. This new route was recently scaled up in 50 L fixed equipment to afford 1.2 kg of drug substance in five steps with an overall yield of 20% and >99% chemical and enantiomeric
CHEMICAL COMPOUNDS
-
Page/Page column 38-39, (2010/11/28)
The present invention provides compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 of a
CHEMICAL COMPOUNDS
-
Page/Page column 44-45, (2008/06/13)
The present invention provides compounds of Formula (I) comprising: including salts, solvates, and physiologically functional derivatives thereof, pharmaceutical formulations containing them, processes for their preparation, and methods of treatment using them.